HRX-233

N/A

Report date: 2025/05/06 11:11:59
NME

Base Information

Drug NameHRX-233
Drug Alias NameHRX-233
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDual specificity mitogen-activated protein kinase kinase 4 inhibitors
TargetsDual specificity mitogen-activated protein kinase kinase 4
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesHepaRegeniX GmbH
China Registration ClassN/A

Develop Information

Active CompaniesHepaRegeniX GmbH
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A